Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3728965018 | Alogliptin only product | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3728966017 | Product containing only alogliptin (medicinal product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 2832351000001113 | Alogliptin (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| 2832361000001111 | Alogliptin | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Alogliptin | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Alogliptin | Is a | Product containing alogliptin | true | Inferred relationship | Existential restriction modifier | ||
| Alogliptin | Has active ingredient | Alogliptin | true | Inferred relationship | Existential restriction modifier | 1 | |
| Alogliptin | Is a | Virtual therapeutic moiety | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing only alogliptin in oral dose form (medicinal product form) | Is a | True | Alogliptin | Inferred relationship | Existential restriction modifier | |
| Alogliptin 12.5mg tablets | Is a | True | Alogliptin | Inferred relationship | Existential restriction modifier | |
| Alogliptin 25mg tablets | Is a | True | Alogliptin | Inferred relationship | Existential restriction modifier | |
| Alogliptin 6.25mg tablets | Is a | True | Alogliptin | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR